PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

dronedarone

Verify with FDA → · CMS NADAC pricing →

Brand names: Multaq

Class III Antiarrhythmic Rx

Multaq is a medicine that helps lower the risk of needing to stay in the hospital for atrial fibrillation (AFib). It is for people who have a history of AFib and are currently in normal heart rhythm.

Drug Pricing (NADAC)

Brand Price

$12.76/unit

Generic Available

No

SANOFI AVENTIS US

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Multaq is used to lower the risk of hospitalization if you have atrial fibrillation (AFib).

Common side effects

Diarrhea, Nausea, Abdominal pain

Key warnings

Multaq can increase the risk of death, stroke, and heart failure in patients with severe heart failure or permanent AFib.

How It Works

Multaq is an antiarrhythmic drug. It works by changing the electrical signals in the heart. This helps to keep your heart in a normal rhythm and prevent AFib from returning.

How to Take It

Take one 400 mg tablet twice a day. Take one tablet with your morning meal and one with your evening meal. Do not start Multaq if you are taking certain other heart medicines or strong CYP3A inhibitors. Make sure you are not pregnant before starting Multaq.

Pregnancy & Breastfeeding

Multaq can harm an unborn baby. If you are a woman who could become pregnant, use effective birth control while taking Multaq. Do not breastfeed while taking Multaq and for 5 days after your last dose.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Storage

Store Multaq at room temperature, between 68°F and 77°F.

Side Effects (from patient reports)

Based on 5,959 FDA adverse event reports.

Irregular heartbeat
1,418
Shortness of breath
834
Tiredness
614
Diarrhea
477
Nausea
471
Interaction with another medicine
467
Feeling dizzy
449
Using the medicine for something it's not approved for
428
Bleeding in the stomach or intestines
420
Weakness
381

FDA Adverse Event Report Analysis

Detailed analysis of 9,899 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2009–2025.

Total Reports

9,899

Death-Related Reports

658

Hospitalization Reports

3,327

Top Indication

Atrial Fibrillation

Gender Distribution

Female 4,811 (53%)
Male 4,229 (46%)

Age Distribution

0–17 16
18–44 108
45–64 1,230
65–74 2,414
75+ 3,019

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 ATRIAL FIBRILLATION 1,420
2 DYSPNOEA 838
3 FATIGUE 615
4 DIARRHOEA 477
5 NAUSEA 472
6 DRUG INTERACTION 467
7 DIZZINESS 449
8 OFF LABEL USE 431
9 GASTROINTESTINAL HAEMORRHAGE 420
10 ASTHENIA 381
11 DRUG INEFFECTIVE 328
12 BLOOD CREATININE INCREASED 312
13 HEADACHE 225
14 CARDIAC FAILURE 221
15 OEDEMA PERIPHERAL 219

Reactions in Death Reports

DEATH 195
GASTROINTESTINAL HAEMORRHAGE 60
DYSPNOEA 49
ATRIAL FIBRILLATION 38
PNEUMONIA 37
RENAL FAILURE 37
CARDIAC ARREST 31
OFF LABEL USE 31
DRUG INTERACTION 28
HYPOTENSION 28

Reactions in Hospitalization Reports

ATRIAL FIBRILLATION 445
GASTROINTESTINAL HAEMORRHAGE 396
DYSPNOEA 349
DRUG INTERACTION 221
ANAEMIA 155
NAUSEA 147
PNEUMONIA 147
DIARRHOEA 145
ASTHENIA 138
FATIGUE 135

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Multaq can increase the risk of death, stroke, and heart failure in patients with severe heart failure or permanent AFib. You should not take this medicine if you have severe heart failure that recently required hospitalization or if you have permanent AFib and will not be converted to a normal heart rhythm.

Known Drug Interactions

7.2 Effects of Other Drugs on Dronedarone Ketoconazole and Other Potent CYP3A Inhibitors Concomitant use of ketoconazole as well as other potent CYP3A inhibitors such as itraconazole, voriconazole, ritonavir, clarithromycin, and nefazodone is contraindicated because exposure to dronedarone is significantly increased [see Contraindications (4) , Clinical Pharmacology (12.3) ] .

Mechanism: Ketoconazole stops the liver enzyme that breaks down dronedarone from working. This causes dronedarone to build up to much higher levels in your body.

What to do: Do not use these medications at the same time. This combination is contraindicated by the manufacturer.

7.2 Effects of Other Drugs on Dronedarone Ketoconazole and Other Potent CYP3A Inhibitors Concomitant use of ketoconazole as well as other potent CYP3A inhibitors such as itraconazole, voriconazole, ritonavir, clarithromycin, and nefazodone is contraindicated because exposure to dronedarone is significantly increased [see Contraindications (4) , Clinical Pharmacology (12.3) ] .

Mechanism: Clarithromycin blocks the process your body uses to clear dronedarone. This leads to a significant increase in the amount of dronedarone in your blood.

What to do: You should not take these two drugs together. Consult your doctor for a safer alternative.

7.2 Effects of Other Drugs on Dronedarone Ketoconazole and Other Potent CYP3A Inhibitors Concomitant use of ketoconazole as well as other potent CYP3A inhibitors such as itraconazole, voriconazole, ritonavir, clarithromycin, and nefazodone is contraindicated because exposure to dronedarone is significantly increased [see Contraindications (4) , Clinical Pharmacology (12.3) ] .

Mechanism: Voriconazole interferes with the way your body breaks down dronedarone. This results in much higher levels of dronedarone, which can be unsafe.

What to do: This drug combination must be avoided. Your doctor will need to adjust your treatment plan.

dronedarone ↑ dronedarone Co-administration is contraindicated due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.

Mechanism: Darunavir raises the level of dronedarone in your blood by slowing its breakdown. This can cause your heart to beat in a dangerous or irregular way.

What to do: This combination is unsafe and should be avoided to prevent serious heart rhythm issues.

Amiodarone, Dronedarone, Ranolazine, or Calcium Channel Blockers Clinical Impact: The risk of myopathy and rhabdomyolysis is increased by concomitant use of amiodarone, dronedarone, ranolazine, or calcium channel blockers with ezetimibe and simvastatin. Intervention: For patients taking verapamil, diltiazem, or dronedarone, do not exceed ezetimibe and simvastatin 10 mg/10 mg daily.

Mechanism: Dronedarone makes it harder for your body to process the cholesterol medicine, which can lead to severe muscle breakdown.

What to do: If you take dronedarone, your daily dose of ezetimibe and simvastatin should not exceed 10 mg/10 mg.

Check all your medications →

Common Questions

Can I take Multaq if I have heart failure?
You should not take Multaq if you have severe heart failure that recently required hospitalization or NYHA Class IV heart failure.
What should I do if I experience side effects?
Tell your doctor if you have any side effects. Some side effects, like liver problems, need immediate medical attention.
Can I drink grapefruit juice while taking Multaq?
No, you should avoid drinking grapefruit juice while taking Multaq.
Will Multaq cure my atrial fibrillation?
Multaq does not cure atrial fibrillation, but it can help reduce the risk of hospitalization.
How often will I need to see my doctor while taking Multaq?
Your doctor will want to check your heart rhythm at least every 3 months.
What other medicines should I avoid while taking Multaq?
Avoid taking Multaq with strong CYP3A inhibitors, erythromycin, or drugs that prolong the QT interval.
Can Multaq cause liver problems?
Yes, Multaq can cause liver problems. Tell your doctor right away if you have symptoms like yellowing of the skin or eyes, dark urine, or stomach pain.
What if I gain weight or have shortness of breath while taking Multaq?
These could be signs of heart failure. Contact your doctor right away.
Can I take Multaq if I am pregnant?
No, Multaq can harm an unborn baby. You should not take Multaq if you are pregnant.
Will Multaq interact with my other medications?
Yes, Multaq can interact with many other medications. Tell your doctor about all the medicines you take.
What are the common side effects of dronedarone?
The most commonly reported side effects of dronedarone include Diarrhea, Nausea, Abdominal pain, Vomiting, Feeling weak or tired. Based on 5,959 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does dronedarone interact with other medications?
Yes, dronedarone has 22 known drug interactions. Notable interactions include ketoconazole, clarithromycin, voriconazole. Always inform your doctor about all medications you are taking.
What drug class is dronedarone?
dronedarone belongs to the Class III Antiarrhythmic drug class. It requires a prescription (Rx). Multaq is used to lower the risk of hospitalization if you have atrial fibrillation (AFib).
Is dronedarone safe during pregnancy?
Multaq can harm an unborn baby. If you are a woman who could become pregnant, use effective birth control while taking Multaq. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Class III Antiarrhythmic

Other drugs grouped near dronedarone — same-class peers and common alternatives.

Compare dronedarone vs adenosine side-by-side →

Medication Guides

Related Health & Safety Data

Save on dronedarone

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for dronedarone

The FDA label for dronedarone (sold under brand names such as Multaq) classifies it as a prescription-only medication in the Class III Antiarrhythmic class. Multaq is used to lower the risk of hospitalization if you have atrial fibrillation (AFib). Official labeling lists 7 commonly reported side effects, including Diarrhea, Nausea, Abdominal pain.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 5,959 voluntary reports. The database also lists 22 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: January 27, 2026

All federal data sources used on this page